RT a16z (@a16z)Innovation does more to keep Big Tech in check than regulation ever could.@balajis says billion-dollar acquisitions are a sign of Big Tech’s weakness. They show what incumbents couldn't build and fund startup piranhas to fill the gaps.Block the exits, and you shut down the next generation. ...

If whiz gets approved, I think every other large Mac7 company is going to see a green light in regards to making big splashy acquisitions again, which is a good thing. You look at Google, Microsoft, Amazon, and Meta combined. I mean, they're doing 600 billion of operating cash flow, just cash coming off the company every single year.And I think they would much rather make very strategic acquisitions than buy back 50 basis points of the. ...

Personally don’t think this is gonna happen and even if, I think people are blinded by the success of Pudgy Penguins and Moonbirds acquisitions. Most takeovers fail, it’s not per se bullish ...

Company Leadership & Strategy - Giovanni Ferrero became the sole leader of his family's candy maker in 2015 [1] - The company has expanded beyond well-known brands like Nutella [1] - Ferrero has built a global powerhouse, especially through acquisitions in the U S [1]

In short: we solve the problem of acquisitions stuck in regulatory limbo by playing the game of regulatory limbo. ...

Ripple eyeing ‘multiple acquisitions,’ Ethereum-like upgrades to XRP Ledger https://t.co/3v6RoWEz23 ...

Core Business Performance - Danaher Corporation has seen strong performance in its bioprocessing business, with orders increasing for the seventh consecutive quarter, and anticipates core revenues to rise in high-single-digits year-over-year for 2025 [1] - The Biotechnology segment is also performing well, with core revenues increasing by 7% year-over-year in the first quarter, and similar growth is expected for 2025 [2] Acquisitions and Growth Strategy - The company acquired Abcam plc for approximately $5.7 billion in December 2023, enhancing its Life Sciences segment and contributing to a 0.5% increase in total revenues in the first quarter [3] Shareholder Returns - Danaher is committed to returning value to shareholders, having paid dividends of $194 million in the first quarter of 2025, compared to $768 million in the same quarter of 2024, and increased its dividend by 18.5% to 32 cents per share in February 2025 [4] Segment Challenges - The Life Sciences segment faced a 4% decline in core revenues year-over-year due to lower demand in academic and government markets, as well as a sales decline in the filtration business [5] - The Diagnostics segment also struggled, with core revenues declining by 1.5% year-over-year due to sluggish demand for respiratory disease tests [8] Financial Position - Danaher reported long-term debt of $16 billion, a 3% increase sequentially, with current liabilities at $6.6 billion, exceeding cash equivalents of $2 billion, and high interest expenses of $72 million in the first quarter [9][10]